Toronto Dominion Bank’s ProShares UltraShort NASDAQ Biotechnology BIS Stock Holding History

Toronto Dominion Bank’s Portfolio BIS Stock Details BIS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-175	Closed	-$22K	–	1491
2018 Q3	$22K	Hold	175	–	–	﹤0.01%	1193
2018 Q2	$27K	Hold	175	–	–	﹤0.01%	1250
2018 Q1	$30K	Hold	175	–	–	﹤0.01%	1155
2017 Q4	$31K	Hold	175	–	–	﹤0.01%	1130
2017 Q3	$29K	Hold	175	–	–	﹤0.01%	1045
2017 Q2	$34K	Hold	175	–	–	﹤0.01%	1080
2017 Q1	$39K	Hold	175	–	–	﹤0.01%	1061
2016 Q4	$49K	Hold	175	–	–	﹤0.01%	1021
2016 Q3	$44K	Hold	175	–	–	﹤0.01%	1046
2016 Q2	$59K	Sell	175 -13	-7%	-$4.11K	﹤0.01%	835
2016 Q1	$65K	Hold	188	–	–	﹤0.01%	841
2015 Q4	$43K	Hold	188	–	–	﹤0.01%	927
2015 Q3	$58K	Buy	188 +63	+50%	+$14.9K	﹤0.01%	899
2015 Q2	$29K	Hold	125	–	–	﹤0.01%	976
2015 Q1	$34K	Hold	125	–	–	﹤0.01%	950
2014 Q4	$46K	Buy	125 +35	+39%	+$14.6K	﹤0.01%	904
2014 Q3	$43K	Buy	90 +40	+80%	+$21.3K	﹤0.01%	807
2014 Q2	$28K	Buy	+50	New	+$34.4K	﹤0.01%	959

Other funds holding BIS

HVC

Healthcare Value Capital Woodcliff Lake, New Jersey $50.7M AUM 24.72% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

GCM

Gunderson Capital Management Mt. Pleasant, South Carolina $370M AUM 211.56% 1-Year Est. Return

TRCT

Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

Toronto Dominion Bank's BIS Position: Q4 2018 in Review

Toronto Dominion Bank sold out of ProShares UltraShort NASDAQ Biotechnology (BIS) in Q4 2018, closing a stake of 175 shares — an estimated $22K sold.

Toronto Dominion Bank first reported a position in BIS in Q2 2014 and held it in 18 quarters. The position peaked at $65K in Q1 2016. 8 funds tracked by Wall St. Rank hold BIS as of Q4 2018.

Toronto Dominion Bank reported no remaining ProShares UltraShort NASDAQ Biotechnology position as of Q4 2018 after selling out during the quarter.
Toronto Dominion Bank sold 175 ProShares UltraShort NASDAQ Biotechnology shares in Q4 2018, an estimated $22K.
Toronto Dominion Bank first reported a position in ProShares UltraShort NASDAQ Biotechnology in Q2 2014 and held it in 18 quarters.
Toronto Dominion Bank's ProShares UltraShort NASDAQ Biotechnology position peaked at $65K in Q1 2016.
8 funds tracked by Wall St. Rank held ProShares UltraShort NASDAQ Biotechnology as of Q4 2018.

Based on Toronto Dominion Bank's 13F filing for Q4 2018, filed 7 Feb 2019.